Glutathione-based delivery system
    1.
    发明授权
    Glutathione-based delivery system 有权
    基于谷胱甘肽的输送系统

    公开(公告)号:US08673863B2

    公开(公告)日:2014-03-18

    申请号:US13287480

    申请日:2011-11-02

    摘要: A delivery system is provided. The delivery system includes a carrier or an active compound and a glutathione or a glutathione derivative grafted thereon. The invention also provides a compound including a moiety comprising a vitamin E derivative or a phospholipid derivative, a polyethylene glycol (PEG) or a polyethylene glycol derivative bonded thereto, and a glutathione (GSH) or a glutathione derivative bonded to the polyethylene glycol or the polyethylene glycol derivative.

    摘要翻译: 提供传送系统。 递送系统包括载体或活性化合物和接枝在其上的谷胱甘肽或谷胱甘肽衍生物。 本发明还提供了包含包含维生素E衍生物或磷脂衍生物,聚乙二醇(PEG)或与其结合的聚乙二醇衍生物的部分的化合物以及与聚乙二醇结合的谷胱甘肽(GSH)或谷胱甘肽衍生物 聚乙二醇衍生物。

    METHODS AND COMPOSITIONS COMPRISING NOVEL CATIONIC LIPIDS
    2.
    发明申请
    METHODS AND COMPOSITIONS COMPRISING NOVEL CATIONIC LIPIDS 有权
    包含新型阳离子脂肪的方法和组合物

    公开(公告)号:US20110117141A1

    公开(公告)日:2011-05-19

    申请号:US12993421

    申请日:2009-05-01

    摘要: Provided herein are novel cationic lipids, compositions comprising the cationic lipids, and methods of using the cationic lipids. In some claims, the cationic lipids have cytotoxic activity and can be used alone or in combination with a cytotoxic bioactive compound to kill a cell. In some of these claims, the cationic lipid enhances the cytotoxic activity of the cytotoxic bioactive compound. Methods for treating a subject afflicted with a disease or unwanted condition are provided, wherein the method comprises administering a delivery system comprising a novel cationic lipid to the subject. The invention further provides methods for making delivery systems comprising the novel cationic lipids of the invention.

    摘要翻译: 本文提供了新型阳离子脂质,包含阳离子脂质的组合物和使用阳离子脂质的方法。 在一些权利要求中,阳离子脂质具有细胞毒性活性,并且可以单独使用或与细胞毒性生物活性化合物组合用于杀死细胞。 在这些权利要求中的一些中,阳离子脂质增强细胞毒性生物活性化合物的细胞毒性活性。 提供了治疗患有疾病或不需要的病症的受试者的方法,其中所述方法包括向所述受试者施用包含新型阳离子脂质的递送系统。 本发明还提供了制备包含本发明的新型阳离子脂质的递送系统的方法。

    Targeted delivery system
    3.
    发明授权
    Targeted delivery system 有权
    目标传送系统

    公开(公告)号:US07803398B2

    公开(公告)日:2010-09-28

    申请号:US11020773

    申请日:2004-12-23

    IPC分类号: A61K9/127

    摘要: A targeting delivery system. The targeted delivery system includes a carrier for a drug and a targeted ligand modifying the carrier to target the encapsulated drug to a sigma receptor over-expressed cell.

    摘要翻译: 定位投放系统 靶向递送系统包括用于药物的载体和修饰载体以将包封的药物靶向西格玛受体过表达细胞的靶向配体。

    Glutathione based delivery system
    4.
    发明授权
    Glutathione based delivery system 有权
    基于谷胱甘肽的输送系统

    公开(公告)号:US07446096B2

    公开(公告)日:2008-11-04

    申请号:US11303934

    申请日:2005-12-19

    IPC分类号: A61K38/00

    摘要: A delivery system. The delivery system includes a carrier or an active compound and a glutathione or a glutathione derivative grafted thereon. The invention also provides a compound including a moiety comprising a vitamin E derivative or a phospholipid derivative, a polyethylene glycol (PEG) or a polyethylene glycol derivative bonded thereto, and a glutathione (GSH) or a glutathione derivative bonded to the polyethylene glycol or the polyethylene glycol derivative.

    摘要翻译: 送货系统。 递送系统包括载体或活性化合物和接枝在其上的谷胱甘肽或谷胱甘肽衍生物。 本发明还提供了包含包含维生素E衍生物或磷脂衍生物,聚乙二醇(PEG)或与其结合的聚乙二醇衍生物的部分的化合物以及与聚乙二醇结合的谷胱甘肽(GSH)或谷胱甘肽衍生物 聚乙二醇衍生物。

    Glutathione based delivery system
    6.
    发明授权
    Glutathione based delivery system 有权
    基于谷胱甘肽的输送系统

    公开(公告)号:US08569239B2

    公开(公告)日:2013-10-29

    申请号:US12721633

    申请日:2010-03-11

    IPC分类号: A61K47/00

    摘要: A delivery system. The delivery system includes a carrier or an active compound and a glutathione or a glutathione derivative grafted thereon. The invention also provides a compound including a moiety comprising a vitamin E derivative or a phospholipid derivative, a polyethylene glycol (PEG) or a polyethylene glycol derivative bonded thereto, and a glutathione (GSH) or a glutathione derivative bonded to the polyethylene glycol or the polyethylene glycol derivative.

    摘要翻译: 送货系统。 递送系统包括载体或活性化合物和接枝在其上的谷胱甘肽或谷胱甘肽衍生物。 本发明还提供了包含包含维生素E衍生物或磷脂衍生物,聚乙二醇(PEG)或与其结合的聚乙二醇衍生物的部分的化合物以及与聚乙二醇结合的谷胱甘肽(GSH)或谷胱甘肽衍生物 聚乙二醇衍生物。

    Methods and compositions comprising novel cationic lipids
    7.
    发明授权
    Methods and compositions comprising novel cationic lipids 有权
    包含新型阳离子脂质的方法和组合物

    公开(公告)号:US08389768B2

    公开(公告)日:2013-03-05

    申请号:US12993421

    申请日:2009-05-01

    摘要: Provided herein are novel cationic lipids, compositions comprising the cationic lipids, and methods of using the cationic lipids. In some claims, the cationic lipids have cytotoxic activity and can be used alone or in combination with a cytotoxic bioactive compound to kill a cell. In some of these claims, the cationic lipid enhances the cytotoxic activity of the cytotoxic bioactive compound. Methods for treating a subject afflicted with a disease or unwanted condition are provided, wherein the method comprises administering a delivery system comprising a novel cationic lipid to the subject. The invention further provides methods for making delivery systems comprising the novel cationic lipids of the invention.

    摘要翻译: 本文提供了新型阳离子脂质,包含阳离子脂质的组合物和使用阳离子脂质的方法。 在一些权利要求中,阳离子脂质具有细胞毒性活性,并且可以单独使用或与细胞毒性生物活性化合物组合用于杀死细胞。 在这些权利要求中的一些中,阳离子脂质增强细胞毒性生物活性化合物的细胞毒性活性。 提供了治疗患有疾病或不需要的病症的受试者的方法,其中所述方法包括向所述受试者施用包含新型阳离子脂质的递送系统。 本发明还提供了制备包含本发明的新型阳离子脂质的递送系统的方法。

    Drug delivery system targeting to estrogen receptor over-expressed cells
    8.
    发明授权
    Drug delivery system targeting to estrogen receptor over-expressed cells 有权
    药物递送系统靶向雌激素受体过表达细胞

    公开(公告)号:US07820204B2

    公开(公告)日:2010-10-26

    申请号:US10747049

    申请日:2003-12-30

    IPC分类号: A61K9/16

    摘要: A vector for targeted delivery of drugs into estrogen receptors over-expressed cells is disclosed. The vector of the present invention is mainly about an active targeting delivery carrier which consists of a plurality of nanoparticles including: (i) a plurality of targeted moiety conjugated to the outer surface of the nanoparticles, the moiety being capable of binding with the estrogen receptor of a target cell, and (ii) bioactive agents encapsulated in the nanoparticles or forming complex with the nanoparticles. The targeted moiety of the present invention can also be conjugated to parent drugs for prodrug design.

    摘要翻译: 公开了用于将药物靶向递送到雌激素受体过表达细胞的载体。 本发明的载体主要涉及由多个纳米颗粒组成的主动靶向递送载体,其包括:(i)与纳米颗粒的外表面缀合的多个靶向部分,所述部分能够与雌激素受体结合 的靶细胞,和(ii)包封在纳米颗粒中或与纳米颗粒形成复合物的生物活性剂。 本发明的靶向部分也可以与母体药物缀合用于前药设计。

    GLUTATHIONE BASED DELIVERY SYSTEM
    9.
    发明申请
    GLUTATHIONE BASED DELIVERY SYSTEM 有权
    基于GLUTATHIONE的交付系统

    公开(公告)号:US20090060991A1

    公开(公告)日:2009-03-05

    申请号:US12263885

    申请日:2008-11-03

    摘要: A delivery system. The delivery system includes a carrier or an active compound and a glutathione or a glutathione derivative grafted thereon. The invention also provides a compound including a moiety comprising a vitamin E derivative or a phospholipid derivative, a polyethylene glycol (PEG) or a polyethylene glycol derivative bonded thereto, and a glutathione (GSH) or a glutathione derivative bonded to the polyethylene glycol or the polyethylene glycol derivative.

    摘要翻译: 送货系统。 递送系统包括载体或活性化合物和接枝在其上的谷胱甘肽或谷胱甘肽衍生物。 本发明还提供了包含包含维生素E衍生物或磷脂衍生物,聚乙二醇(PEG)或与其结合的聚乙二醇衍生物的部分的化合物以及与聚乙二醇结合的谷胱甘肽(GSH)或谷胱甘肽衍生物 聚乙二醇衍生物。

    Glutathione based delivery system
    10.
    发明授权
    Glutathione based delivery system 有权
    基于谷胱甘肽的输送系统

    公开(公告)号:US07700564B2

    公开(公告)日:2010-04-20

    申请号:US12263885

    申请日:2008-11-03

    IPC分类号: A61K38/06 A61K51/08

    摘要: A delivery system. The delivery system includes a carrier or an active compound and a glutathione or a glutathione derivative grafted thereon. The invention also provides a compound including a moiety comprising a vitamin E derivative or a phospholipid derivative, a polyethylene glycol (PEG) or a polyethylene glycol derivative bonded thereto, and a glutathione (GSH) or a glutathione derivative bonded to the polyethylene glycol or the polyethylene glycol derivative.

    摘要翻译: 送货系统。 递送系统包括载体或活性化合物和接枝在其上的谷胱甘肽或谷胱甘肽衍生物。 本发明还提供了包含包含维生素E衍生物或磷脂衍生物,聚乙二醇(PEG)或与其结合的聚乙二醇衍生物的部分的化合物以及与聚乙二醇结合的谷胱甘肽(GSH)或谷胱甘肽衍生物 聚乙二醇衍生物。